ID   TC-CD99-shRNA#2
AC   CVCL_QW73
DR   cancercelllines; CVCL_QW73
DR   GEO; GSM278145
DR   GEO; GSM278146
DR   Wikidata; Q54971826
RX   PubMed=20197622;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; 7082; CD99.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2213 ! TC-71
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 11
//
RX   PubMed=20197622; DOI=10.1172/JCI36667;
RA   Rocchi A., Manara M.C., Sciandra M., Zambelli D., Nardi F.,
RA   Nicoletti G., Garofalo C., Meschini S., Astolfi A., Colombo M.P.,
RA   Lessnick S.L., Picci P., Scotlandi K.;
RT   "CD99 inhibits neural differentiation of human Ewing sarcoma cells and
RT   thereby contributes to oncogenesis.";
RL   J. Clin. Invest. 120:668-680(2010).
//